- OGN Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Organon & Co. (OGN) Financial statements
Company Profile
Dec 2023 | Dec 2022 | Dec 2021 | ||
---|---|---|---|---|
Total Revenue | ||||
Cost of Revenue | ||||
Gross Profit | ||||
Gross Profit Margin (%) | ||||
R&D Expense | ||||
SG&A Expense | ||||
Total Operating Expenses | ||||
Operating Income or Loss | ||||
Operating Margin (%) | ||||
Interest Expense | ||||
Total Other Income/Expenses | ||||
Income Before Tax | ||||
Income Tax Expense | ||||
Income from Continuing Ops. | ||||
Net Income | ||||
Net Profit Margin (%) | ||||
Net Income Available to Common Shareholders | ||||
Basic EPS | ||||
Diluted EPS | ||||
Basic Average Shares | ||||
Diluted Average Shares |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||||||
Cost of Revenue | ||||||||||||||||
Gross Profit | ||||||||||||||||
Gross Profit Margin (%) | ||||||||||||||||
R&D Expense | ||||||||||||||||
SG&A Expense | ||||||||||||||||
Total Operating Expenses | ||||||||||||||||
Operating Income or Loss | ||||||||||||||||
Operating Margin (%) | ||||||||||||||||
Interest Expense | ||||||||||||||||
Total Other Income/Expenses | ||||||||||||||||
Income Before Tax | ||||||||||||||||
Income Tax Expense | ||||||||||||||||
Income from Continuing Ops. | ||||||||||||||||
Net Income | ||||||||||||||||
Net Profit Margin (%) | ||||||||||||||||
Net Income Available to Common Shareholders | ||||||||||||||||
Basic EPS | ||||||||||||||||
Diluted EPS | ||||||||||||||||
Basic Average Shares | ||||||||||||||||
Diluted Average Shares |
Dec 2023 | Dec 2022 | Dec 2021 | ||
---|---|---|---|---|
Current Assets | ||||
Cash & Cash Equivalents | ||||
Marketable Securities | ||||
Receivables | ||||
Inventories | ||||
Other Current Assets | ||||
Total Current Assets | ||||
Non-Current Assets | ||||
Marketable Securities | ||||
PPE Net | ||||
Intangibles inc. Goodwill | ||||
Other Non-Current Assets | ||||
Total Non-Current Assets | ||||
Total Assets | ||||
Current Liabilities | ||||
Accounts Payable | ||||
Deferred Revenues | ||||
Debt, Current | ||||
Accrued Liabilities | ||||
Other Current Liabilities | ||||
Total Current Liabilities | ||||
Non-Current Liabilities | ||||
Deferred Revenues | ||||
Debt, Non-Current | ||||
Other Non-Current Liabilities | ||||
Total Non-Current Liabilities | ||||
Total Liabilities | ||||
Shareholders' Equity | ||||
Common Stock | ||||
Additional Paid-In Capital | ||||
Retained Earnings | ||||
Other Shareholders' Equity | ||||
Total Shareholders' Equity | ||||
Total Liabilities & Shareholders' Equity |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||||||
Cash & Cash Equivalents | ||||||||||||||||
Marketable Securities | ||||||||||||||||
Receivables | ||||||||||||||||
Inventories | ||||||||||||||||
Other Current Assets | ||||||||||||||||
Total Current Assets | ||||||||||||||||
Non-Current Assets | ||||||||||||||||
Marketable Securities | ||||||||||||||||
PPE Net | ||||||||||||||||
Intangibles inc. Goodwill | ||||||||||||||||
Other Non-Current Assets | ||||||||||||||||
Total Non-Current Assets | ||||||||||||||||
Total Assets | ||||||||||||||||
Current Liabilities | ||||||||||||||||
Accounts Payable | ||||||||||||||||
Deferred Revenues | ||||||||||||||||
Debt, Current | ||||||||||||||||
Accrued Liabilities | ||||||||||||||||
Other Current Liabilities | ||||||||||||||||
Total Current Liabilities | ||||||||||||||||
Non-Current Liabilities | ||||||||||||||||
Deferred Revenues | ||||||||||||||||
Debt, Non-Current | ||||||||||||||||
Other Non-Current Liabilities | ||||||||||||||||
Total Non-Current Liabilities | ||||||||||||||||
Total Liabilities | ||||||||||||||||
Shareholders' Equity | ||||||||||||||||
Common Stock | ||||||||||||||||
Additional Paid-In Capital | ||||||||||||||||
Retained Earnings | ||||||||||||||||
Other Shareholders' Equity | ||||||||||||||||
Total Shareholders' Equity | ||||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2023 | Dec 2022 | Dec 2021 | ||
---|---|---|---|---|
Cash Flows from Operating Activities | ||||
Net Income | ||||
Depreciation & Amortization | ||||
Deferred Income Taxes | ||||
Stock Based Compensation | ||||
Accounts Receivable | ||||
Inventory | ||||
Accounts Payable | ||||
Deferred Revenue | ||||
Other Non-Cash | ||||
Operating Cash Flow | ||||
Cash Flows from Investing Activities | ||||
PPE Investments | ||||
Net Acquisitions | ||||
Purchase of Investments | ||||
Sale of Investments | ||||
Other Investing Activity | ||||
Investing Cash Flow | ||||
Cash Flows from Financing Activities | ||||
Debt Issued | ||||
Proceeds from Debt Repayment | ||||
Debt Repayment | ||||
Proceeds from Sale of Equity | ||||
Equity Repurchased | ||||
Dividend Paid | ||||
Other Financing Activity | ||||
Financing Cash Flow | ||||
Cash Position | ||||
Beginning Cash Position | ||||
End Cash Position | ||||
Change in Cash | ||||
Free Cash Flow | ||||
Operating Cash Flow | ||||
Capital Expenditure | ||||
Free Cash Flow |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||||||
Net Income | ||||||||||||||||
Depreciation & Amortization | ||||||||||||||||
Deferred Income Taxes | ||||||||||||||||
Stock Based Compensation | ||||||||||||||||
Accounts Receivable | ||||||||||||||||
Inventory | ||||||||||||||||
Accounts Payable | ||||||||||||||||
Deferred Revenue | ||||||||||||||||
Other Non-Cash | ||||||||||||||||
Operating Cash Flow | ||||||||||||||||
Cash Flows from Investing Activities | ||||||||||||||||
PPE Investments | ||||||||||||||||
Net Acquisitions | ||||||||||||||||
Purchase of Investments | ||||||||||||||||
Sale of Investments | ||||||||||||||||
Other Investing Activity | ||||||||||||||||
Investing Cash Flow | ||||||||||||||||
Cash Flows from Financing Activities | ||||||||||||||||
Debt Issued | ||||||||||||||||
Proceeds from Debt Repayment | ||||||||||||||||
Debt Repayment | ||||||||||||||||
Proceeds from Sale of Equity | ||||||||||||||||
Equity Repurchased | ||||||||||||||||
Dividend Paid | ||||||||||||||||
Other Financing Activity | ||||||||||||||||
Financing Cash Flow | ||||||||||||||||
Cash Position | ||||||||||||||||
Beginning Cash Position | ||||||||||||||||
End Cash Position | ||||||||||||||||
Change in Cash | ||||||||||||||||
Free Cash Flow | ||||||||||||||||
Operating Cash Flow | ||||||||||||||||
Capital Expenditure | ||||||||||||||||
Free Cash Flow |